Affluent Medical Bolsters Team with Key Appointments

On March 11, 2025, Affluent Medical, a French clinical-stage medtech company, announced three key leadership appointments to strengthen its market access strategy. Dr. Howard C. Herrmann and Pr. Nicolas Barry Delongchamps have been appointed as Chief Medical Officers (CMO) for the Structural Heart and Urology Platforms, respectively. Dr. Herrmann, an interventional cardiologist, and Pr. Delongchamps, a skilled urologist, will guide advancements in their specialized areas, focusing on innovative devices like the KALIOS mitral ring and the ARTUS urinary sphincter.

In tandem, Federica Azzimonti joins as Director of Clinical Operations, enhancing operational readiness for imminent clinical trials. With 25 years of experience, Federica will oversee trial execution, ensuring seamless implementation. According to CEO Sébastien Ladet, these appointments mark a critical growth phase as Affluent Medical progresses towards commercializing its advanced medical solutions.